Division of Diabetes Endocrinology and Metabolism

May 23, 2022

Vanderbilt Diabetes Day celebrates investigational achievements, looks toward future

Vanderbilt Diabetes Day, an annual event that showcases the work of outstanding scientists and researchers in the fields of diabetes, obesity and metabolism was held this month, and it marked the first time many investigators working under the auspices of the Vanderbilt Diabetes Research and Training Center (DRTC) had gathered in one space since the beginning of the COVID-19 pandemic.

By Jill Clendening
March 24, 2022

Reducing obesity-related inflammation

A treatment that increases levels of lipid signaling molecules reduced adipose tissue inflammation in obese adults, suggesting this pathway may be a valuable target for modulating fat and systemic inflammation.

By VUMC News and Communications
February 21, 2022

VUMC mourns loss of dedicated clinician, teacher Fowler

Vanderbilt’s Michael Fowler, MD, associate professor of Medicine in the Division of Diabetes, Endocrinology and Metabolism, a celebrated Master Clinical Teacher, and co-medical director of the Shade Tree Clinic, died Feb. 20. He was 49.

By Kathy Whitney
January 17, 2022

Inaugural members of the Vanderbilt Academy for Excellence in Clinical Medicine announced

The inaugural members of the Vanderbilt Academy for Excellence in Clinical Medicine (AECM) have been chosen.

By John Howser
November 11, 2021

International gathering scrutinizes immune response, beta cell biology in Type 1 diabetes

By Jill Clendening
October 28, 2021

Pancreatic beta-cell booster

Blocking inflammatory signaling improves beta-cell characteristics in a mouse model of type 2 diabetes and may provide added benefits to GLP-1R diabetes medications.

By Leigh MacMillan
August 27, 2021

Study proves standardized protocol can support reliable MRI use for multisite pancreatic research

Researchers with the Vanderbilt Diabetes Research and Training Center (DRTC) at Vanderbilt University Medical Center led a multisite study which has demonstrated that, when controlled and standardized, quantitative magnetic resonance imaging (MRI) of the pancreas is highly reproducible when using different MRI hardware and software at different geographic locations.
By Jill Clendening
August 10, 2021

Vitamin D impact on disease biomarkers

In a randomized controlled trial, vitamin D supplementation did not improve biomarkers for cardiovascular and metabolic disease.
By Leigh MacMillan
June 21, 2021

Two VUMC physician-scientists win Burroughs Wellcome Fund Career Awards

Two physician-scientist Instructors in Medicine at Vanderbilt University Medical Center (VUMC) — Jeeyeon Cha, MD, PhD, and Celestine Wanjalla, MD, PhD — are among 12 recipients of the 2021 Burroughs Wellcome Fund (BWF) Career Award for Medical Scientists.
By Bill Snyder
May 20, 2021

Beta cell regeneration

Vanderbilt researchers dissected the complex microenvironment of the pancreatic islet to discover the signals that drive beta cell regeneration — as a possible treatment for diabetes.
By Leigh MacMillan
February 18, 2021

Gene variant and glucose metabolism

Genetic variation that impacts glucose- and insulin-related signaling affects responses to type 2 diabetes treatments and warrants further study.
By Leigh MacMillan
December 22, 2020

Pancreatlas provides access to complex images of the human pancreas

Images of cells and tissues are a critical part of biomedical research as they show which molecules or proteins are present and where these molecules are located in the tissue. Using increasingly sophisticated microscopes and imaging approaches, scientists can now look at more than 40 different molecules at once, an approach known as multi-plex imaging, where in the past they could only look at three or four molecules at a time.
By Jill Clendening
December 10, 2020

Study sheds light on diabetes and COVID interaction

COVID-19 has been linked to cases of new-onset diabetes, diabetes-related emergencies and a higher death rate among diabetes patients.
By Bill Snyder
1 2 3 4 5 … 7